Qube Research & Technologies (QRT)’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.2M | Sell |
412,666
-74,469
| -15% | -$1.77M | 0.01% | 1267 |
|
|
2025
Q4 | $11.4M | Sell |
487,135
-334,067
| -41% | -$7.44M | 0.02% | 1264 |
|
|
2025
Q3 | $16.2M | Sell |
821,202
-193,208
| -19% | -$3.97M | 0.02% | 1013 |
|
|
2025
Q2 | $22M | Buy |
1,014,410
+254,114
| +33% | +$6M | 0.03% | 826 |
|
|
2025
Q1 | $18.4M | Buy |
760,296
+101,044
| +15% | +$2.28M | 0.03% | 790 |
|
|
2024
Q4 | $13.8M | Sell |
659,252
-7,988
| -1% | -$172K | 0.02% | 904 |
|
|
2024
Q3 | $13.3M | Buy |
667,240
+538,506
| +418% | +$9.98M | 0.02% | 868 |
|
|
2024
Q2 | $1.99M | Buy |
128,734
+38,484
| +43% | +$599K | ﹤0.01% | 1627 |
|
|
2024
Q1 | $1.44M | Buy |
+90,250
| New | +$1.36M | ﹤0.01% | 1934 |
|
|
2023
Q4 | – | Sell |
-64,578
| Closed | -$755K | – | 4403 |
|
|
2023
Q3 | $755K | Buy |
+64,578
| New | +$864K | ﹤0.01% | 1855 |
|
|
2023
Q1 | – | Sell |
-121,873
| Closed | -$2.27M | – | 2601 |
|
|
2022
Q4 | $2.27M | Buy |
+121,873
| New | +$1.88M | 0.01% | 899 |
|
|
2022
Q3 | – | Sell |
-122,638
| Closed | -$860K | – | 2566 |
|
|
2022
Q2 | $860K | Sell |
122,638
-31,071
| -20% | -$228K | 0.01% | 1164 |
|
|
2022
Q1 | $1.27M | Sell |
153,709
-24,611
| -14% | -$174K | 0.01% | 1043 |
|
|
2021
Q4 | $1.21M | Buy |
178,320
+93,818
| +111% | +$617K | 0.01% | 1078 |
|
|
2021
Q3 | $448K | Buy |
84,502
+40,238
| +91% | +$220K | 0.01% | 1269 |
|
|
2021
Q2 | $255K | Buy |
+44,264
| New | +$228K | ﹤0.01% | 1667 |
|
|
2020
Q2 | – | Sell |
-34,024
| Closed | -$131K | – | 1745 |
|
|
2020
Q1 | $131K | Buy |
+34,024
| New | +$140K | 0.01% | 930 |
|
Other funds holding CPRX
VCM
DM
VPM